China Imaging-based Biobank of Cerebral Small Vessel Diseases A National Study to Evaluate Imaging and Clinical Outcomes

What this Trial Is About

Researchers are building a national comprehensive platform to evaluate cerebral small vessel diseases (CSVD) by collecting imaging-based medical data over time. This study aims to propose new classification and diagnostic criteria, establish risk prediction models, and identify high-risk populations early to reduce the future burden of CSVD in China. The study explores multiple factors including imaging signs, cognition, gait, autonomic nervous system, hemodynamics, sleep, emotion, and eye health. Participants with CSVD will be observed without intervention. The study involves longitudinal data collection including imaging and clinical assessments. The primary group consists of patients with CSVD as identified by MRI. Data on different CSVD types and their risk factors will be gathered to support the development of new diagnostic and prognostic tools. During participation, patients will undergo evaluations including MRI scans and assessments of neurological function, cognition, gait, and other health measures. Researchers will monitor outcomes such as the number of patients diagnosed, functional status (mRS score) over five years, and new vascular events. Participation involves long-term follow-up to study disease progression and outcomes, with no treatment administered as part of the study.

China Imaging-based Biobank of Cerebral Small Vessal Diseases